BiotechTube
Home/Interna TX/Joel Van Gelder, Ph.D.
JV

Joel Van Gelder, Ph.D.

Chief Innovation Officer

Interna TX

Therapeutic Areas

Infectious diseasesPulmonary diseases

Interna TX Pipeline

DrugIndicationPhase
MNM‑siRNA COVID‑19SARS‑CoV‑2 infection (COVID‑19)Phase 1
MNM‑siRNA RSVRespiratory syncytial virusPreclinical
MNM‑siRNA IPFIdiopathic pulmonary fibrosisPreclinical

Leadership Team at Interna TX

YG
Yuval Gottenstein
CEO
GK
Guy Kornberg, Ph.D.
COO
HG
Hagit Grimberg, Ph.D.
Executive VP, R&D
RD
Roger D. Kornberg
Scientific President
View full Interna TX profile